ARCHIVES

Texas Oncology Designated Aranesp As Preferred Treatment

This article is from The Cancer Letter archive.

Vol. 28 No. 46 | December 13, 2002

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Coalition Demonstrations Crucial To Obtaining Windfall

October 16, 1992

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Moloney Out As Viral Oncology Chief, Names “Acting Assistant Director” Of NCI By Upton

January 6, 1978

Obit: Shirley Lansky, 66, Illinois Cancer Center Director, Dead.

November 30, 2001

In Brief: Center wins $10 Million To coordinate Study; Albert Einstein Center Name Comprehensive

December 5, 1997

NCI News: Biospecimen Banks Program for NCTN

November 22, 2013